Gönczi L - Search Results

1

[Outcomes of variceal upper gastrointestinal bleeding: A prospective, multicenter, population-based study from West Hungary].

Lakatos L, Gönczi L, Izbéki F, Patai Á, Rácz I, Gasztonyi B, Varga-Szabó L, Barnabás Á, Iliás Á, Lakatos PL. Lakatos L, et al. Among authors: gonczi l. Orv Hetil. 2021 Aug 1;162(31):1252-1259. doi: 10.1556/650.2021.32166. Orv Hetil. 2021. PMID: 34333456 Hungarian.

2

Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.

Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gönczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL. Kurti Z, et al. Among authors: gonczi l. World J Gastroenterol. 2015 Jun 7;21(21):6728-35. doi: 10.3748/wjg.v21.i21.6728. World J Gastroenterol. 2015. PMID: 26074711 Free PMC article.

3

Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.

Kurti Z, Lovasz BD, Gecse KB, Balint A, Farkas K, Morocza-Szabo A, Gyurcsanyi A, Kristof K, Vegh Z, Gonczi L, Kiss LS, Golovics PA, Lakatos L, Molnar T, Lakatos PL. Kurti Z, et al. Among authors: gonczi l. J Gastrointestin Liver Dis. 2015 Dec;24(4):467-72. doi: 10.15403/jgld.2014.1121.244.bcg. J Gastrointestin Liver Dis. 2015. PMID: 26697573 Free article.

4

Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.

Vegh Z, Kurti Z, Gonczi L, Golovics PA, Lovasz BD, Szita I, Balogh M, Pandur T, Vavricka SR, Rogler G, Lakatos L, Lakatos PL. Vegh Z, et al. Among authors: gonczi l. Scand J Gastroenterol. 2016 Jul;51(7):848-54. doi: 10.3109/00365521.2016.1140807. Epub 2016 Feb 16. Scand J Gastroenterol. 2016. PMID: 26880133

5

Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database.

Kurti Z, Vegh Z, Golovics PA, Fadgyas-Freyler P, Gecse KB, Gonczi L, Gimesi-Orszagh J, Lovasz BD, Lakatos PL. Kurti Z, et al. Among authors: gonczi l. Dig Liver Dis. 2016 Nov;48(11):1302-1307. doi: 10.1016/j.dld.2016.07.012. Epub 2016 Jul 21. Dig Liver Dis. 2016. PMID: 27481587

6

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

Gonczi L, Vegh Z, Golovics PA, Rutka M, Gecse KB, Bor R, Farkas K, Szamosi T, Bene L, Gasztonyi B, Kristóf T, Lakatos L, Miheller P, Palatka K, Papp M, Patai Á, Salamon Á, Tóth GT, Vincze Á, Biro E, Lovasz BD, Kurti Z, Szepes Z, Molnár T, Lakatos PL. Gonczi L, et al. J Crohns Colitis. 2017 Jun 1;11(6):697-705. doi: 10.1093/ecco-jcc/jjw203. J Crohns Colitis. 2017. PMID: 27838610

7

[Indications, diagnoses and quality markers in upper and lower endoscopies in 2010 and 2011 at the 1st Department of Medicine, Semmelweis University, Budapest].

Gönczi L, Kürti Z, Golovics P, Végh Z, Lovász B, Dorkó A, Seres A, Sümegi L, Menyhárt O, Kiss L, Papp J, Gecse K, Lakatos PL. Gönczi L, et al. Orv Hetil. 2016 Dec;157(52):2074-2081. doi: 10.1556/650.2016.30602. Orv Hetil. 2016. PMID: 28019112 Hungarian.

8

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.

Gonczi L, Kurti Z, Rutka M, Vegh Z, Farkas K, Lovasz BD, Golovics PA, Gecse KB, Szalay B, Molnar T, Lakatos PL. Gonczi L, et al. BMC Gastroenterol. 2017 Aug 8;17(1):97. doi: 10.1186/s12876-017-0654-1. BMC Gastroenterol. 2017. PMID: 28789636 Free PMC article.

9

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort.

Gonczi L, Gecse KB, Vegh Z, Kurti Z, Rutka M, Farkas K, Golovics PA, Lovasz BD, Banai J, Bene L, Gasztonyi B, Kristof T, Lakatos L, Miheller P, Nagy F, Palatka K, Papp M, Patai A, Salamon A, Szamosi T, Szepes Z, Toth GT, Vincze A, Szalay B, Molnar T, Lakatos PL. Gonczi L, et al. Inflamm Bowel Dis. 2017 Nov;23(11):1908-1915. doi: 10.1097/MIB.0000000000001237. Inflamm Bowel Dis. 2017. PMID: 28922253

10

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies.

Gonczi L, Kurti Z, Golovics PA, Lovasz BD, Menyhart O, Seres A, Sumegi LD, Gal A, Ilias A, Janos P, Gecse KB, Bessisow T, Afif W, Bitton A, Vegh Z, Lakatos PL. Gonczi L, et al. Dig Liver Dis. 2018 Jan;50(1):37-41. doi: 10.1016/j.dld.2017.09.137. Epub 2017 Oct 9. Dig Liver Dis. 2018. PMID: 29107471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page